We examined subcategories of breast cancer (invasive breast cancer versus ductal carcinoma in situ (DCIS), estrogen-receptor/progesterone-receptor (ER/PR) positive versus negative, and hormone receptor negative and HER2 negative (triple negative) versus others) in relation to menstrually-related and other migraine. This evidence concerns the gene NR4A1 and migraine disorder.